For inquiries regarding the utilization of ethnobotanicals, or in case you are experiencing an adverse situation or difficulty integrating and experience, please read this page. For inquiries regarding legal support , please read this page.
This paper evaluates clinical studies of ibogaine with a focus on administration settings, with the goal to identify specific criteria that may promote safer contexts for ibogaine use.
An acquittal was given in Mexico City in the trial of Don Jose Campos, a 64-year-old indigenous healer from the Peruvian Amazon who was arrested and imprisoned in March of 2022 for traveling with ayahuasca.
Journalist, photographer and anthropologist, Carlos Suárez is one of the westerners who best knows the reality of the Amazon jungle. Suárez has been living for seven years in Leticia, capital of the Colombian Amazon, a few hours by boat from Iquitos, the epicenter of ayahuasca tourism. The author explains how the ayahuasca tourist has redirected his faith from the spirits to the molecules of ayahuasca.
“Ayahuasca told me…” is a phrase often heard in integration circles, where people literally interpret messages as being “from the plant” as opposed to via their own internal world. David, ICEERS Support Center Coordinator, shares further insight.
Mexico is facing a historic opportunity to reverse past situations that have colonized the legal system by classifying mushrooms as prohibited substances due to the implications of international drug control treaties, despite their longstanding cultural and traditional significance safeguarded by Mexican Indigenous peoples.
ICEERS and colleagues have published a new paper offering the most detailed report thus far on the topic, Adverse Effects of Ayahuasca: Results from the Global Ayahuasca Survey, in the open-access journal PLOS Global Public Health.
ICEERS supports the development of evidence-informed policies and is committed to advancing clinical research. To support the collective knowledge on these topics, our organization launched the first-ever Phase II clinical trial in 2020 examining the efficacy of ibogaine for opioid dependence and detox from methadone.
This article, which is Part 1 in a series outlining ideas and perspectives from the Support Centre, is an interview with David where he speaks in depth about the complexity of ego dissolution as related to master plant experiences.
The new fundraising and education platform Grow Medicine provides people interested in iboga, ayahuasca, toad, peyote, and mushrooms the opportunity to learn more about conservation issues and to donate to support Indigenous-led initiatives.
When it comes to integration therapy, Marc Aixalà has witnessed a vast evolution being shaped by the increasing interest in psychedelics. He was the first person to field people’s requests for guidance when the ICEERS Integration and Support Centre opened in 2013. He then volunteered to assist people having challenging psychedelic experiences at festivals in Europe.
Ibogaine activist and entrepreneur, Robert Rand (also known as Bob Sisko) was one of the pioneers of the early ibogaine movement in the 1970s. He recently passed away at the age of 75 after a battle with liver cancer. To honor his memory, ICEERS spoke with his son Noah Rand and important figures who knew Sisko during different stages of life.
A new report Coca Leaf in Court: Cultural Rights and the Toxicological Labyrinth published by Constanza Sánchez, Dr. José Carlos Bouso, Pien Metaal, and Roberto Castro highlights the concerns with how coca cases are addressed in Spain, and the precedence this sets in other parts of the world.
Psychoactive plants and fungi are becoming more well-known, and we are beginning to hear more about amphibians whose secretions are also able to alter consciousness. The toad known as “Bufo” is increasingly being talked about in the media and online forums. The Latin nomenclature of Bufo alvarius is often used to refer to a species of toad that produces large quantities of the psychoactive substance 5-MeO-DMT within its specialized skin glands, most prominently, its parotid glands. But this infamous amphibian goes by many other names, scientific or otherwise, which we will get into more detail about here.
According to a newly released study published in the Journal of Psychoactive Drugs, ayahuasca may help support a healthy lifestyle. The long-term impact investigation was carried out by the Research team at ICEERS, in collaboration with the Autonomous University of Madrid, University Rovira i Virgili, University of São Paulo, and Leiden University. The study assessed 377 participants taking part in ayahuasca ceremonies in the Netherlands.
In March 2022, Italy’s government made the two principal ingredients of ayahuasca Schedule I controlled substances. Read our comments here.
ICEERS started the first ever Phase II clinical trial exploring the potential of ibogaine to treat opioid dependency. Click here to learn more.
Dr. José Carlos Bouso, ICEERS’ Scientific Director, will participate in the subcommittee of the Congress to study the regulation of therapeutic cannabis in Spain, contributing his vision as an expert in the field of medical cannabis.
The 2021 Ayahuasca Technical Report includes 26 pages with all the latest research-based facts about ayahuasca, its uses, pharmacology, legal status and therapeutic effects, signed by 11 world-class experts and researchers.
The guide was initially published in three languages – Catalan, Spanish and English – and since then it has taken on a life of its own. The number of translations has grown to more than a dozen, and it has become, in its own right, the guide of choice for facilitators and participants for ayahuasca ceremonies outside the Amazonian context. This post reveals the inside story of how the guide came about, as told by its protagonists.
Constanza Sánchez, José Carlos Bouso, Natalia Rebollo | April 2021 In March 2020, the results of a significant trial related ayahuasca importation in Spain concluded with an acquittal that paves the way for the future
Ricard Faura, Andrea Langlois | April 2021 When ICEERS decided to begin the Iboga and Ibogaine Community Engagement Initiative, we were responding to a community request. Many people in the international community dedicated to iboga
It is hard to walk a path you cannot see. A collective vision can serve as a guiding light, supporting community leaders, visionaries, practitioners, and policy-makers as we navigate through unknown terrain. It helps us remain focused on a future even though the exact path there is not yet fully illuminated. The purpose of the Iboga/ine Community Engagement Initiative was to engage with the global community to crowdsource opinions and ideas about what an ideal future looks like for iboga and ibogaine in global society.
The sudden interruption of almost all maritime, air, and land travel worldwide due to the pandemic has opened the door for many communities to reflect on interdependences within a globalized world, particularly when it comes to “supply chains” for clothing, food, and plant medicines. One of the key impacts for communities that work with teacher plants (such as ayahuasca) outside of the Amazon has been the need to reconsider how they are procuring medicine for their ceremonies.
This post is Part 2 in a series exploring the impact of the pandemic on ayahuasca communities (read Part 1). ICEERS seeks to support the community by providing a bird’s eye perspective on trends, movements, and the bridge between traditional practices and emerging ones. After the pandemic hit, we took the time to speak with a handful of individuals involved or are well acquainted with communities in Europe, North America, Central America and South America.
